Compile Data Set for Download or QSAR
maximum 50k data
Found 42 with Last Name = 'wiltse' and Initial = 'al'
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044210(7-[2-(4-methylpiperazin-1-yl)ethoxy]-8-methyl-2-mo...)
Affinity DataIC50:  850nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044219(6,8-Dimethyl-7-[2-(4-methyl-piperazin-1-yl)-ethoxy...)
Affinity DataIC50:  1.40E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044221(7-(1-tert-Butyl-1H-tetrazol-5-ylmethoxy)-8-methyl-...)
Affinity DataIC50:  2.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044183(7-(2-Diethylamino-ethoxy)-8-methyl-2-morpholin-4-y...)
Affinity DataIC50:  2.60E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044209(8-Methyl-7-(1-methyl-1H-tetrazol-5-ylmethoxy)-2-mo...)
Affinity DataIC50:  2.80E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044194(7-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-2-morpholin...)
Affinity DataIC50:  3.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044204(7-(2-Azepan-1-yl-ethoxy)-8-methyl-2-morpholin-4-yl...)
Affinity DataIC50:  3.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044213(8-Ethyl-7-[2-(4-methyl-piperazin-1-yl)-ethoxy]-2-m...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044188(8-Methyl-2-morpholin-4-yl-7-(pyridin-3-ylmethoxy)-...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044208(8-Methyl-2-morpholin-4-yl-7-(2-piperazin-1-yl-etho...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044216(8-Methyl-2-morpholin-4-yl-7-(2-morpholin-4-yl-etho...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044215(8-Methyl-2-morpholin-4-yl-7-(2-pyrrolidin-1-yl-eth...)
Affinity DataIC50:  4.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044207(8-Methyl-2-morpholin-4-yl-7-(2-thiomorpholin-4-yl-...)
Affinity DataIC50:  4.30E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044192(8-Methyl-2-morpholin-4-yl-7-(2-piperidin-1-yl-etho...)
Affinity DataIC50:  5.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044217(7-(2-Methoxy-ethoxy)-8-methyl-2-morpholin-4-yl-chr...)
Affinity DataIC50:  7.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044185(8-Methyl-2-morpholin-4-yl-7-(1-phenyl-1H-tetrazol-...)
Affinity DataIC50:  8.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044200(8-Allyl-7-[2-(4-methyl-piperazin-1-yl)-ethoxy]-2-m...)
Affinity DataIC50:  8.90E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044186((8-Methyl-2-morpholin-4-yl-4-oxo-4H-chromen-7-ylox...)
Affinity DataIC50:  9.00E+3nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044193(7-[2-(4-Benzyl-piperazin-1-yl)-ethoxy]-8-methyl-2-...)
Affinity DataIC50:  1.10E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044223(7-{2-[4-(2-Hydroxy-ethyl)-piperazin-1-yl]-ethoxy}-...)
Affinity DataIC50:  1.20E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044184(7-(1-Cyclohexyl-1H-tetrazol-5-ylmethoxy)-8-methyl-...)
Affinity DataIC50:  1.20E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044218(8-Methyl-2-morpholin-4-yl-7-(2-oxo-propoxy)-chrome...)
Affinity DataIC50:  1.20E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044189(8-Methyl-2-morpholin-4-yl-7-(naphthalen-1-ylmethox...)
Affinity DataIC50:  1.30E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044190(8-Methyl-7-(2-methylsulfanyl-ethoxy)-2-morpholin-4...)
Affinity DataIC50:  1.40E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044214(7-{2-[Ethyl-(2-hydroxy-ethyl)-amino]-ethoxy}-8-met...)
Affinity DataIC50:  1.40E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044206(8-Methyl-2-morpholin-4-yl-7-(pyridin-2-ylmethoxy)-...)
Affinity DataIC50:  1.90E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044224(7-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-2-morpholin...)
Affinity DataIC50:  3.50E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044197(7-(benzyloxy)-8-methyl-2-morpholino-4H-chromen-4-o...)
Affinity DataIC50:  4.00E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044191(7-Methoxy-8-methyl-2-morpholin-4-yl-chromen-4-one ...)
Affinity DataIC50:  4.10E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044220(2-Morpholin-4-yl-7-(naphthalen-1-ylmethoxy)-chrome...)
Affinity DataIC50:  4.10E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044196(8-Methyl-2-morpholin-4-yl-7-(2-oxo-2-phenyl-ethoxy...)
Affinity DataIC50:  4.30E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044202(7-[2-(Ethyl-phenyl-amino)-ethoxy]-8-methyl-2-morph...)
Affinity DataIC50:  4.30E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044199(7-(2-Methoxy-benzyloxy)-8-methyl-2-morpholin-4-yl-...)
Affinity DataIC50:  4.40E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044211(7-(4-Methoxy-benzyloxy)-8-methyl-2-morpholin-4-yl-...)
Affinity DataIC50:  4.70E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044222(2-Morpholin-4-yl-7-(pyridin-2-ylmethoxy)-chromen-4...)
Affinity DataIC50:  5.30E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044205(7-Allyloxy-8-methyl-2-morpholin-4-yl-chromen-4-one...)
Affinity DataIC50:  5.80E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044195((3,8-Dimethyl-2-morpholin-4-yl-4-oxo-4H-chromen-7-...)
Affinity DataIC50:  5.90E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044198(8-Methyl-2-morpholin-4-yl-7-(naphthalen-2-ylmethox...)
Affinity DataIC50:  6.50E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044201(7-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-2-morpholin...)
Affinity DataIC50:  6.90E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044212(8-Methyl-2-morpholin-4-yl-7-[2-(4-phenyl-piperazin...)
Affinity DataIC50: >7.50E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044203(3,8-Dimethyl-2-morpholin-4-yl-7-(naphthalen-1-ylme...)
Affinity DataIC50: >7.50E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Upjohn Laboratories

Curated by ChEMBL
LigandPNGBDBM50044187(7-Benzyloxy-3,8-dimethyl-2-morpholin-4-yl-chromen-...)
Affinity DataIC50: >7.50E+4nMAssay Description:In vitro inhibitory activity against ADP-induced human platelet aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed